New Study Examines Impact of Manufacturer Coupons on GLP-1 Drug Spending

A new study published in the *Journal of General Internal Medicine* investigates how manufacturer coupons influence both patient and payer spending for GLP-1 receptor agonist treatments. The research highlights that while these coupons can reduce immediate out-of-pocket costs for patients, they may also steer them towards higher-cost brand-name medications and obscure true pricing signals in the healthcare system.